Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of neural transmission

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s007020050206PMID 10599868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiparkinsonian effect of flupirtine in monoamine-depleted rats

  2005cited by this paper
• [Potassium channel opener].

  2000cited by this paper
• Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonist.

  1998cited by this paper
• Flupirtine: A Review of Its Neuroprotective and Behavioral Properties

  1998influential reference
• Effect of the triaminopyridine flupirtine on calcium uptake, membrane potential and ATP synthesis in rat heart mitochondria

  1998cited by this paper
• Influence of flupirtine on a G‐protein coupled inwardly rectifying potassium current in hippocampal neurones

  1997cited by this paper
• Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

  1997cited by this paper
• The Potassium Channel Opener (−)‐Cromakalim Prevents Glutamate‐Induced Cell Death in Hippocampal Neurons

  1997cited by this paper
• Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.

  1996cited by this paper
• Protection of rabbit retina from ischemic injury by flupirtine.

  1996influential reference
• K+ channel openers protect hippocampal neurons against oxidative injury and amyloid beta-peptide toxicity.

  1996cited by this paper
• Effects of K+ channel blockers and openers on antinociception induced by agonists of 5-HT1A receptors.

  1996cited by this paper
• K+ channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity

  1996cited by this paper
• Influence of flupirtine on human lower limb reflexes.

  1995influential reference
• Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration.

  1995influential reference
• Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.

  1995cited by this paper
• Flupirtine partially prevents neuronal injury induced by prion protein fragment and lead acetate.

  1995cited by this paper
• N-methyl-D-aspartate and alpha 2-adrenergic mechanisms are involved in the depressant action of flupirtine on spinal reflexes in rats.

  1995influential reference
• Immunohistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate and homocysteic acid-induced release of GABA in the rabbit retina.

  1994influential reference
• Distribution and localization of a G protein‐coupled inwardly rectifying K+ channel in the rat

  1994cited by this paper
• N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of flupirtine in rats.

  1994cited by this paper
• The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1.

  1994influential reference
• Flupirtine protects against ischaemic retinal dysfunction in rats.

  1994influential reference
• Whole cell and single channel analysis of the kinetics of glycine‐sensitive N‐methyl‐D‐aspartate receptor desensitization

  1993cited by this paper
• Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states.

  1993cited by this paper
• Differential effects of K+ channel blockers on antinociception induced by alpha 2-adrenoceptor, GABAB and kappa-opioid receptor agonists.

  1993cited by this paper
• The pharmacology of pain signalling.

  1993cited by this paper
• Differential effects of K+ channel blockers on antinociception induced by α2‐adrenoceptor, GABAB and κ‐opioid receptor agonists

  1993cited by this paper
• Protection of rabbit retina from ischemic injury by superoxide dismutase and catalase.

  1993cited by this paper
• Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).

  1993cited by this paper
• Pinacidil potentiates morphine analgesia.

  1992cited by this paper
• Cromakalim (BRL 34915) counteracts the epileptiform activity elicited by diltiazem and verapamil in rats

  1991cited by this paper
• Investigations with the novel non-opioid analgesic flupirtine in regard to possible benzodiazepine-like abuse inducing potential.

  1990cited by this paper
• Effects of potassium channel openers on pentylenetetrazole-induced seizures in mice.

  1990cited by this paper
• [The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].

  1990cited by this paper
• An ATP-dependent potassium channel blocker antagonizes morphine analgesia.

  1990cited by this paper
• Potassium channel activators abolish excitotoxicity in cultured hippocampal pyramidal neurons.

  1990cited by this paper
• Mode of antinociceptive action of flupirtine in the rat

  1989influential reference
• Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine

  1989cited by this paper
• K+ channel openers decrease seizures in genetically epileptic rats.

  1989cited by this paper
• Pharmacokinetics of flupirtine in elderly volunteers and in patients with moderate renal impairment.

  1988cited by this paper
• Depression by flupirtine, a novel analgesic agent, of motor and sensory responses of the nociceptive system in the rat spinal cord.

  1987cited by this paper
• The antinociceptive activity of flupirtine: a structurally new analgesic.

  1987cited by this paper
• [Mechanism of action of the analgesic flupirtine].

  1985cited by this paper
• Substance P raises neuronal membrane excitability by reducing inward rectification

  1985cited by this paper
• [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog].

  1985cited by this paper
• [Pharmacokinetics and biotransformation of the analgesic flupirtine in humans].

  1985cited by this paper
• The action of flupirtine on prostaglandin formation and platelet aggregation in vitro.

  1985cited by this paper

• Mechanism-based nonopioid analgesic targets

  2025cites this paper
• Persistent Na+ current couples spreading depolarization to seizures in Scn8a gain of function mice.

  2025cites this paper
• Kv7 channel opener retigabine reduces self‐administration of cocaine but not sucrose in rats

  2024cites this paper
• Persistent Na+ current couples spreading depolarization to seizures in Scn8a gain of function mice

  2024cites this paper
• Neuroprotection by 4R-cembranoid against Gulf War Illness-related chemicals is mediated by ERK, PI3K, and CaMKII pathways.

  2024cites this paper
• EFFICACY AND TOLERABILITY OF FLUPIRTINE MALEATE VERSUS DICLOFENAC IN MECHANICAL LOW BACK PAIN – A PROSPECTIVE COMPARATIVE STUDY

  2024cites this paper
• Current status of GABA receptor subtypes in analgesia.

  2023cites this paper
• Long-term potentiation and its neurotrophin-dependent modulation in the superior cervical ganglion of the rat are influenced by KCNQ channel function.

  2023cites this paper
• Kv7 Channel Opener Retigabine Reduces Self-Administration of Cocaine but Not Sucrose in Rats

  2023cites this paper
• Identification of a Subtype-Selective Allosteric Inhibitor of GluN1/GluN3 NMDA Receptors

  2022cites this paper
• Ligand modulation of KCNQ-encoded (KV7) potassium channels in the heart and nervous system.

  2021cites this paper
• Age dependent effects of Retigabine on absence seizure in WAG/Rij rats; an experimental study

  2021cites this paper
• Advances in Targeting GIRK Channels in Disease.

  2021cites this paper
• Activation of KCNQ (KV7) K+ channels in enteric neurons inhibits epithelial Cl- secretion in mouse distal colon.

  2021cites this paper
• Chemical modulation of Kv7 potassium channels.

  2021cites this paper
• Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020

  2021cites this paper
• Flupirtine enhances NHE-3 mediated Na+ absorption in rat colon via an ENS-dependent mechanism.

  2021cites this paper
• Systematic review of pharmacological management in Creutzfeldt-Jakob disease: no options so far?

  2021cites this paper
• An iPSC-Derived Neuron Model of CLN3 Disease Facilitates Small Molecule Phenotypic Screening.

  2020cites this paper
• Effects of a potassium channel opener on brain injury and neurologic outcomes in an animal model of neonatal hypoxic-ischemic injury

  2019cites this paper
• RESEARCH ARTICLE Analytical Method for Development and Validation of Flupirtine Maleate by Reverse-phase High-performance Liquid Chromatography

  2019cites this paper
• A Study to Find out Additive Analgesic Effect of Flupirtine Maleate, Tramadol Hydrochloride and Paracetamol in Experimental Pain Management in Mice

  2019cites this paper
• Pharmacology of Kv7 channels in rat pulmonary artery

  2019cites this paper
• Concise review: Therapeutic potential of flupirtine maleate

  2019cites this paper
• Pharmacology and clinical applications of flupirtine: Current and future options

  2019cites this paper
• NOVEL APPLICATION OF MIXED HYDROTROPIC SOLUBILIZATION TECHNIQUE IN THE FORMULATION AND EVALUATION OF SOLID DISPERSION OF FLUPIRTINE MALEATE

  2018cites this paper
• Brain Distribution and Metabolism of Flupirtine, a Nonopioid Analgesic Drug with Antiseizure Effects, in Neonatal Rats

  2018cites this paper
• EVALUATION OF BRONCHIAL SMOOTH MUSCLE RELAXANT ACTIVITY OF FLUPIRTINE IN EXPERIMENTALLY INDUCED ASTHMA IN GUINEA PIGS

  2017cites this paper
• Anticonvulsant effect of flupirtine in an animal model of neonatal hypoxic‐ischemic encephalopathy

  2017influential citation
• Effect of flupirtine on seizure activity and its interactions with antiepileptic drugs in rats.

  2017cites this paper
• Analgesic Potential of Extracts and Derived Natural Products from Medicinal Plants

  2017cites this paper
• Bioequivalence study of two formulations of flupirtine maleate capsules in healthy male chinese volunteers under fasting and fed conditions

  2017cites this paper
• Discovery of Aromatic Carbamates that Confer Neuroprotective Activity by Enhancing Autophagy and Inducing the Anti-Apoptotic Protein B-Cell Lymphoma 2 (Bcl-2).

  2017cites this paper
• Rebalancing β-Amyloid-Induced Decrease of ATP Level by Amorphous Nano/Micro Polyphosphate: Suppression of the Neurotoxic Effect of Amyloid β-Protein Fragment 25-35

  2017cites this paper
• Bioequivalence study of two formulations of flupirtine maleate capsules in healthy male Chinese volunteers under fasting and fed conditions

  2017cites this paper
• Anticonvulsant Action of Flupirtine and its Interaction with Antiepileptic Drugs in Rats

  2016cites this paper
• Glutamate receptor antagonists for tinnitus

  2016cites this paper
• Schädlicher Gebrauch und Abhängigkeit von Analgetika

  2016cites this paper
• Schädlicher Gebrauch und Abhängigkeit von Analgetika

  2016cites this paper
• Flupirtine dependence and withdrawal syndrome

  2016cites this paper
• Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs).

  2016cites this paper
• HLA-DRB1*16: 01-DQB1*05 02 is a novel genetic risk factor for flupirtine-induced liver injury

  2016cites this paper
• Synergistic interaction between tapentadol and flupirtine in the rat orafacial formalin test.

  2015influential citation
• δ Subunit‐containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine

  2015influential citation
• The indirect NMDAR inhibitor flupirtine induces sustained post-ischemic recovery, neuroprotection and angioneurogenesis

  2015cites this paper
• Effects of advanced age and renal dysfunction on the single- and repeated-dose pharmacokinetics of modified-release flupirtine.

  2015cites this paper
• Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1.

  2015cites this paper
• Amylase Activity in Albino Rats Treated With Painkil Tablets ( Analgesic )

  2015cites this paper
• Gamma Glutamyl Transferase Activity ( Ggt ) In Albino Rats Treated With Orphenadol Analgesics 1

  2015cites this paper
• A rare case of flupirtine induced loss of speech.

  2015cites this paper
• [Long-term-treatment of chronic pain patients with flupirtine--on hepatotoxicity and persistent effectiveness from 7 months to 22 years].

  2014cites this paper
• A NOVEL STABILITY-INDICATING RP-HPLC METHOD FOR THE ESTIMATION OF FLUPIRTINE IN PHARMACEUTICAL DOSAGE FORMS

  2014cites this paper
• Zur Langzeitbehandlung chronischer Schmerzpatienten mit Flupirtin

  2014cites this paper
• Effect of flupirtine on the growth and viability of U373 malignant glioma cells

  2013cites this paper
• Flupirtine, a re-discovered drug, revisited

  2013cites this paper
• Therapy in prion diseases.

  2013cites this paper
• Dependence on Flupirtine

  2013cites this paper
• Long-term Use of Flupirtine Leads to Withdrawal Symptoms and is Associated with Dependency

  2013cites this paper
• Clinical pharmacology of analgesics assessed with human experimental pain models: bridging basic and clinical research

  2013cites this paper
• Excitation–Inhibition Epilepsies

  2013cites this paper
• Flupirtine: A Review on its Therapeutic Potency

  2013cites this paper
• Abuse liability of flupirtine revisited: Implications of spontaneous reports of adverse drug reactions

  2013cites this paper
• Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro.

  2012cites this paper
• Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study

  2012cites this paper
• Flupirtine: A Human Drug with Potential for Use in the Veterinary Field

  2012cites this paper
• Flupirtine enhances the anti-hyperalgesic effects of morphine in a rat model of prostate bone metastasis.

  2012cites this paper
• The evolving understanding of the analgesic mechanism of action of flupirtine

  2012cites this paper
• Concomitant facilitation of GABAA receptors and KV7 channels by the non‐opioid analgesic flupirtine

  2012influential citation
• Comparative study of efficacy and tolerability of flupirtine versus tramadol in non-steroidal anti-inflammatory drug intolerant mechanical low back pain

  2012cites this paper
• Efficient synthesis of flupirtine analogues derived from pyrimidine

  2012cites this paper
• Kapitel 5 – Therapie

  2012cites this paper
• ON THE MECHANISM OF ACTION OF THE NON-OPIOID ANALGESIC FLUPIRTINE

  2011influential citation
• Pharmazeutische Zubereitung und deren Verwendung

  2011cites this paper
• Correlation versus Causation? Pharmacovigilance of the Analgesic Flupirtine Exemplifies the Need for Refined Spontaneous ADR Reporting

  2011cites this paper
• Combination Therapy for Neuropathic Pain

  2011cites this paper
• A TICO VULSA T ACTIVITY OF FLUPIRTI E I ALBI O MICE

  2011cites this paper
• Efficacy and tolerability of flupirtine in subacute/ chronic musculoskeletal pain - results of a patient level, pooled re-analysis of randomized, double-blind, controlled trials.

  2011cites this paper
• Flupirtine antinociception in the rat orofacial formalin test: an analysis of combination therapies with morphine and tramadol.

  2011cites this paper
• Bundesärztekammer Kassenärztliche Bundesvereinigung Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften

  2011cites this paper
• ATICOVULSAT ACTIVITY OF FLUPIRTIE I

  2011cites this paper
• Flupirtine-induced hepatic failure requiring orthotopic liver transplant.

  2011cites this paper
• Bioanalytical method development, validation and quantification of flupirtine maleate in rat plasma by liquid chromatography-tandem mass spectrometry

  2011cites this paper
• Neuroprotective agents in glaucoma therapy: recent developments and future directions

  2010cites this paper
• CNSB004 (Leconotide) causes antihyperalgesia without side effects when given intravenously: a comparison with ziconotide in a rat model of diabetic neuropathic pain.

  2010cites this paper
• Flupirtine in Pain Management

  2010cites this paper
• Vascular KCNQ Potassium Channels as Therapeutic Targets in Cerebral Vasospasm

  2010cites this paper
• Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.

  2010cites this paper
• Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical Applications

  2010cites this paper
• The Kv7 potassium channel activator flupirtine affects clinical excitability parameters of myelinated axons in isolated rat sural nerve

  2010influential citation
• Flupirtin add-on zu IFN β-1b bei RRMS

  2010cites this paper
• Positive reinforcing effects of flupirtine--two case reports.

  2010cites this paper
• Activation of pre‐synaptic M‐type K+ channels inhibits [3H]d‐aspartate release by reducing Ca2+ entry through P/Q‐type voltage‐gated Ca2+channels

  2009cites this paper
• Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound

  2009cites this paper
• The older patient during normal rheumatological progression

  2009cites this paper
• Investigation of the in Vitro Metabolism of the Analgesic Flupirtine

  2009cites this paper
• Preclinical compounds for the treatment of overactive bladder

  2009cites this paper
• Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind

  2008cites this paper
• Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial*

  2008cites this paper
• Antihyperalgesic and analgesic properties of the N‐methyl‐d‐aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia

  2008influential citation
• G-Protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidazoline receptor selective ligands

  2008cites this paper